Clinical Trial: Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Effectiveness and Safety of uFSH for Severe Oligospermia or Azoospermia:A Multi-center,Open,Randomized,Interventional,and Phase4 Trial in China
Brief Summary: The purpose of this study is to determine whether uFSH is effective and safe in the treatment of male patients with severe oligospermia or azoospermia.
Detailed Summary:
Sponsor: Livzon Pharmaceutical Group Inc.
Current Primary Outcome:
- Sperm density [ Time Frame: 6 month ]
- (A + B)grade sperm and sperm activity rate [ Time Frame: 6 month ]
- A grade sperm [ Time Frame: 6 month ]
- semen volume [ Time Frame: 6 month ]
- sex hormone levels [ Time Frame: 6 month ]
- testis volume [ Time Frame: 6 month ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Livzon Pharmaceutical Group Inc.
Dates:
Date Received: December 2, 2014
Date Started: August 2014
Date Completion:
Last Updated: December 4, 2014
Last Verified: August 2014